Stephanie Song is a Rheumatology/Immunology physician. OpenAlex indexes 7 publications with 291 citations (h-index 3).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
21832 Cactus Ave
Riverside, CA 925183010
Telephone
951-924-6500Provider last certified this registry record 20 Sept 2023.
Industry payments
20 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202538 payments
- Amgen Inc.Program year202516 payments
- UCB, Inc.Program year202511 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
31.7%Folate Analog Metabolic Inhibitor20%Methotrexate100%Part D≥55 patientsTNF inhibitor6%Enbrel Sureclick43%Humira(Cf) Pen25%Enbrel16%Humira(Cf)16%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
19.5%Corticosteroid12.3%Prednisone100%Part D≥40 patientsAntidiarrheal microorganisms6.2%Folic Acid100%Part D≥32 patients+ 1 more class in this area
Nervous system
18.7%Gabapentinoids6%Gabapentin100%Part D≥36 patientsSNRI5.9%Duloxetine Hcl100%Part D≥29 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Development of a cell free virus free beads-based SARS-Cov-2 virus neutralization assay
The Journal of Immunology
2022 - Gut and vaginal microbiomes on steroids: implications for women’s health
Trends in Endocrinology and Metabolism
2021 - SUN-198 Vaginal Microbial Diversity Changes across the Menstrual Cycle in Healthy Young Women
Journal of the Endocrine Society
2019
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”